1. Introduction {#sec1-ijms-20-05378}
===============

Peptidylarginine deiminases (PADs) are phylogenetically conserved calcium-dependent enzymes that post-translationally convert arginine into citrulline in target proteins in an irreversible manner. This can cause structural changes in target proteins and affect protein function, gene regulation and generation of neoepitopes \[[@B1-ijms-20-05378],[@B2-ijms-20-05378],[@B3-ijms-20-05378],[@B4-ijms-20-05378],[@B5-ijms-20-05378],[@B6-ijms-20-05378]\]. Such post-translational changes in proteins may also allow for protein moonlighting, an evolutionary acquired phenomenon facilitating proteins to exhibit several physiologically relevant functions from within one polypeptide chain \[[@B7-ijms-20-05378],[@B8-ijms-20-05378]\].

PADs and associated protein deimination are crucial players in cancer, autoimmune and neurodegenerative diseases \[[@B4-ijms-20-05378],[@B5-ijms-20-05378],[@B6-ijms-20-05378],[@B9-ijms-20-05378]\], with recent indications also for PAD-mediated mechanisms in ageing \[[@B10-ijms-20-05378]\]. Furthermore, critical roles have been identified for PADs and PAD-mediated protein deimination in response to hypoxia and in CNS regeneration \[[@B11-ijms-20-05378],[@B12-ijms-20-05378],[@B13-ijms-20-05378],[@B14-ijms-20-05378],[@B15-ijms-20-05378]\] as well as in tissue remodelling and immunity \[[@B16-ijms-20-05378],[@B17-ijms-20-05378],[@B18-ijms-20-05378]\]. Importantly, PADs have been found to have key roles in the regulation of extracellular vesicle (EV) release \[[@B19-ijms-20-05378],[@B20-ijms-20-05378],[@B21-ijms-20-05378],[@B22-ijms-20-05378]\]. EVs are found in most body fluids and participate in cellular communication via transfer of cargo proteins and genetic material \[[@B6-ijms-20-05378],[@B23-ijms-20-05378],[@B24-ijms-20-05378],[@B25-ijms-20-05378],[@B26-ijms-20-05378]\]. EVs isolated from serum, plasma and other body fluids can therefore be useful health biomarkers \[[@B27-ijms-20-05378],[@B28-ijms-20-05378]\]. Hitherto, work on EVs has mainly been in the context of human pathologies and recent comparative immunology studies on EVs and EV cargo have been performed \[[@B29-ijms-20-05378]\], including the assessment of deiminated EV protein cargo \[[@B30-ijms-20-05378],[@B31-ijms-20-05378],[@B32-ijms-20-05378]\].

PADs have been identified throughout phylogeny from bacteria to mammals, with five tissue specific PAD isozymes in mammals, three in chicken, one in bony and cartilaginous fish \[[@B1-ijms-20-05378],[@B16-ijms-20-05378],[@B17-ijms-20-05378],[@B31-ijms-20-05378],[@B33-ijms-20-05378]\] and PAD homologues in parasites \[[@B34-ijms-20-05378]\], fungi \[[@B35-ijms-20-05378]\] and bacteria \[[@B22-ijms-20-05378]\]. While five PAD isozymes have been described in the naked mole-rat (PADI1, Gene ID: 101722077; PADI2, Gene ID: 101721485; PADI3, Gene ID: 101722435; PADI4, Gene ID: 101722785; PADI6, Gene ID: 101723122), no studies have been carried out on their deiminated protein products or the putative physiological relevance of such post-translational deimination in the physiology of the naked mole-rat.

The naked mole-rat is a burrowing rodent and eusocial mammal, and the only species in the genus *Heterochephalus* of the family *Heterochepalidae* \[[@B36-ijms-20-05378],[@B37-ijms-20-05378]\]. They have a set of highly unusual physical traits, many of which are thought to derive from their highly-social and putatively hypoxic and hypercapnic subterranean lifestyle. For example, naked mole-rats are among the most hypoxia-tolerant mammal presently identified and tolerate minutes of anoxia, hours at 3% O~2~, and days to weeks at 8% O~2~ \[[@B38-ijms-20-05378],[@B39-ijms-20-05378],[@B40-ijms-20-05378],[@B41-ijms-20-05378]\]. The key to tolerating prolonged hypoxia is to match metabolic demand to reduced energy (O~2~) supply \[[@B42-ijms-20-05378],[@B43-ijms-20-05378],[@B44-ijms-20-05378],[@B45-ijms-20-05378]\], and in acute severe hypoxia (3% O~2~), the metabolic rate of adult naked mole-rats decreases up to 85% \[[@B40-ijms-20-05378]\]. However, naked mole-rats remain conscious and active, albeit to a reduced degree \[[@B46-ijms-20-05378],[@B47-ijms-20-05378],[@B48-ijms-20-05378]\]. These findings indicate that naked mole-rats are capable of significant metabolic plasticity within their natural environment. Conversely, naked mole-rats are largely non-responsive to hypercapnia and associated acidity-related pain responses are largely absent \[[@B49-ijms-20-05378],[@B50-ijms-20-05378]\]. Naked mole-rats also have numerous adaptations that are not as obviously linked to their natural habitat, including a remarkable resistance to cancer \[[@B51-ijms-20-05378],[@B52-ijms-20-05378]\], they are the only mammalian thermo-conformer and almost entirely ectothermic for regulation of body temperature \[[@B53-ijms-20-05378],[@B54-ijms-20-05378]\] and they have remarkable longevity \[[@B55-ijms-20-05378],[@B56-ijms-20-05378],[@B57-ijms-20-05378],[@B58-ijms-20-05378]\]. These traits make the naked mole-rat an important animal model for a range of human diseases and for furthering understanding of pathways underlying cancer resistance and longevity \[[@B59-ijms-20-05378],[@B60-ijms-20-05378],[@B61-ijms-20-05378]\]. However, little is known about the immune system of naked mole-rats. As PAD-mediated pathways and EVs are increasingly recognized as key players in immune responses and metabolism, and related to a range of human inflammatory pathologies and cancer, a study on these parameters in mole-rat is warranted.

In the current study, plasma and plasma-derived EVs were profiled in naked mole-rats and assessed for deiminated protein profiles as well as three key microRNAs (miRs) related to inflammation and hypoxic resistance. For the first time we report on post-translational deimination of key immune and metabolic proteins in naked mole-rat and species-specific EV profiles.

2. Results {#sec2-ijms-20-05378}
==========

2.1. PAD Homologues in Naked Mole-Rat Plasma {#sec2dot1-ijms-20-05378}
--------------------------------------------

Using PAD-isozyme specific antibodies, generated against human PADs, positive bands were observed by Western blotting and indicated PAD homologue proteins in mole-rat plasma at the expected size of approximately 70--75 kDa for PAD2, PAD3 and PAD4 ([Figure 1](#ijms-20-05378-f001){ref-type="fig"}A).

2.2. Deiminated Protein Profiles of Naked Mole-Rat Plasma and Plasma-Derived EVs {#sec2dot2-ijms-20-05378}
--------------------------------------------------------------------------------

Total deiminated proteins were detected by Western blotting with the pan-deimination F95 antibody in mole-rat plasma and plasma-derived EVs, revealing a range of proteins mainly between 50--150 kDa ([Figure 1](#ijms-20-05378-f001){ref-type="fig"}B). The mono-specific F95 antibody was used in this study for the identification of deiminated proteins, as it has been developed against a deca-citrullinated peptide and is predicted to react with all deiminated/citrullinated proteins based on 100% sequence homology (MABN328 Merck), and it has been used to identify deiminated proteins in human and animals from diverse taxa \[[@B11-ijms-20-05378],[@B12-ijms-20-05378],[@B16-ijms-20-05378],[@B18-ijms-20-05378],[@B19-ijms-20-05378],[@B21-ijms-20-05378],[@B22-ijms-20-05378],[@B31-ijms-20-05378]\]. Deiminated proteins in mole-rat were also detected in the plasma-derived EVs, mainly in the size range of 20--100 kDa ([Figure 1](#ijms-20-05378-f001){ref-type="fig"}C). Deiminated protein candidates in plasma and EVs were further identified by F95 enrichment (see F95 enriched fraction from plasma assessed by Western blotting, [Figure 1](#ijms-20-05378-f001){ref-type="fig"}D) and LC-MS/MS analysis ([Table 1](#ijms-20-05378-t001){ref-type="table"} and [Table 2](#ijms-20-05378-t002){ref-type="table"}; [Supplementary Tables S1 and S2](#app1-ijms-20-05378){ref-type="app"}). In plasma, 112 species-specific protein hits were identified ([Table 1](#ijms-20-05378-t001){ref-type="table"} and [Supplementary Table S1](#app1-ijms-20-05378){ref-type="app"}) while in EVs, 80 protein hits were identified ([Table 2](#ijms-20-05378-t002){ref-type="table"} and [Supplementary Table S2](#app1-ijms-20-05378){ref-type="app"}). Overall, 48 proteins overlapped between plasma and plasma-derived EVs, while 65 proteins were specific for whole plasma only and 42 proteins for EVs only ([Figure 2](#ijms-20-05378-f002){ref-type="fig"}). The protein lists for deiminated proteins identified in naked mole-rat plasma and plasma-EVs were submitted to STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis (<https://string-db.org/>) to predict putative protein-protein interaction networks ([Figure 3](#ijms-20-05378-f003){ref-type="fig"} and [Figure 4](#ijms-20-05378-f004){ref-type="fig"}).

2.3. Characterisation of Extracellular Vesicles in Naked Mole-Rat Plasma {#sec2dot3-ijms-20-05378}
------------------------------------------------------------------------

EVs isolated from naked mole-rat plasma were characterised for size distribution using nanoparticle tracking analysis (NTA; [Figure 5](#ijms-20-05378-f005){ref-type="fig"}A), by Western blotting using EV-specific markers ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}B) and by morphological analysis using transmission electron microscopy (TEM; [Figure 5](#ijms-20-05378-f005){ref-type="fig"}C). A poly-dispersed population of EVs mainly in the size range of 50 to 300 nm was observed, with some variations between individual animals ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}A), and also with respect to EV yield from plasma ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}D) and modal EV size ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}E). Overall, the main EV peaks were detected at approximately 100--140 nm ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}A,E), with the modal size of EVs falling mainly in the range of 90--115 nm, although this varied somewhat between animals and some outliers were detected ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}E). Western blotting confirmed that the naked mole-rat EVs were positive for the EV-specific markers CD63 and Flot-1 ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}B). Typical EV morphology was confirmed by TEM ([Figure 5](#ijms-20-05378-f005){ref-type="fig"}C).

2.4. MicroRNA Analysis of Naked Mole-Rat EVs {#sec2dot4-ijms-20-05378}
--------------------------------------------

EVs isolated from naked mole-rat plasma were assessed for the relative expression of the immune- and cancer-related miR21, the inflammatory-related miR155 and the metabolic- and hypoxia-related miR210. The highest relative miR levels of the three miRs tested, were observed for miR21 in naked mole-rat plasma-EVs, 394-fold higher than for miR155 and 153-fold higher than for miR210, respectively ([Figure 6](#ijms-20-05378-f006){ref-type="fig"}A). The relative expression of the hypoxia- and metabolic-related miR210 was 2.6--fold higher than the inflammatory miR155 ([Figure 6](#ijms-20-05378-f006){ref-type="fig"}B), which overall showed comparatively the lowest relative levels of expression of the three miRs tested ([Figure 6](#ijms-20-05378-f006){ref-type="fig"}A,B).

3. Discussion {#sec3-ijms-20-05378}
=============

For the first time, post-translationally deiminated proteins are described in naked mole-rat (*Heterocephalus glaber*) plasma, unravelling novel aspects of post-translational deimination of key proteins involved in immune defences and metabolism. PAD homologues were identified in naked mole-rat plasma by Western blotting via cross reaction with human PAD2, which is the phylogenetically most conserved form of PAD \[[@B1-ijms-20-05378],[@B16-ijms-20-05378],[@B31-ijms-20-05378]\]. PAD-positive protein bands were also observed for PAD3 and PAD4, via cross-reaction with PAD isozyme-specific human antibodies, at an expected size of approximately 70 kDa, similar to that reported for other mammalian PADs. Such protein detection corresponds with PAD isozymes that have been identified in the naked mole-rat genome (PADI1, Gene ID: 101722077; PADI2, Gene ID: 101721485; PADI3, Gene ID: 101722435; PADI4, Gene ID: 101722785; PADI6, Gene ID: 101723122). Deiminated proteins were detected and identified both in whole plasma and in plasma-derived EVs. The identity of specific deimination protein candidates in plasma and plasma-EVs was assessed using F95-enrichment in tandem with LC-MS/MS analysis. The F95 mono-specific antibody used in the current study was developed against a deca-citrullinated peptide and has been verified to detect deiminated/citrullinated proteins in diverse taxa \[[@B11-ijms-20-05378],[@B12-ijms-20-05378],[@B16-ijms-20-05378],[@B18-ijms-20-05378],[@B19-ijms-20-05378],[@B21-ijms-20-05378],[@B22-ijms-20-05378],[@B31-ijms-20-05378]\]. In the naked mole-rat, species-specific protein hits revealed 48 common deiminated proteins in plasma and EVs by F95-enrichment, which included some key immune and metabolic related proteins, while 65 deiminated protein hits were specific for plasma and 42 deiminated protein hits specific for EVs only.

As assessed by STRING analysis, the PPI enrichment *p*-value for deiminated proteins identified in naked mole-rat plasma and as cargo in plasma-derived EVs was found to be \<1.0 × 10^−16^ for both. Such an enrichment value indicates that the identified network of proteins has significantly more interactions than expected. Therefore, these deiminated proteins have more interactions among themselves than would be expected for a random set of proteins of similar size, drawn from the genome. Such an enrichment indicates that the proteins, as a group, are at least partially biologically connected. Deiminated target proteins identified in whole naked mole-rat plasma belonged to the following KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways: complement coagulation cascade, platelet activation, cholesterol metabolism, vitamin digestion and adsorption, drug metabolism as well as bacterial infection (*Staphylococcus aureus* and pertussis), autoimmunity (systemic lupus erythematosus) and prion diseases ([Figure 3](#ijms-20-05378-f003){ref-type="fig"}B). Deiminated target proteins identified in EVs of naked mole-rat plasma belonged to KEGG pathways of the complement coagulation cascade, platelet activation, HIF- (hypoxia-inducible factor) signalling pathway, glycolysis/gluconeogenesis, cholesterol metabolism, vitamin digestion and adsorption, oestrogen signalling pathway, as well as bacterial infection (*Staphylococcus aureus*) and autoimmunity (systemic lupus erythematosus) ([Figure 4](#ijms-20-05378-f004){ref-type="fig"}B).

Of interest is that deiminated protein candidates involved in KEGG-pathways for HIF-1-signalling, the master regulator of oxygen homeostasis, seem enriched in the plasma-EVs, indicating a role for EV-mediated transport of such proteins in hypoxic signalling. It is worth noting that naked mole-rats have a high endogenous expression of HIF due to mutation in the VHL (Von Hippel-Lindau disease tumor suppressor) domain \[[@B62-ijms-20-05378]\], which could possibly explain the elevated HIF-1 signalling related targets identified here. Furthermore, deiminated proteins identified in EVs were also enriched for glycolysis and gluconeogenesis KEGG pathways. Our findings indicate that protein deimination may play hitherto unidentified roles in the unusual hypoxia resistance and metabolism of the naked mole-rat, including via EV-transport in cellular communication, also under normal physiological conditions. In addition, the presence of deiminated histone H2B and H4 in EVs may be of some interest as histone deimination is well known to contribute to epigenetic regulation including in cancer \[[@B4-ijms-20-05378],[@B6-ijms-20-05378]\], and the naked mole-rat has been found to have a particularly stable epigenome, which may contribute to the cancer resistance and longevity observed in these animals \[[@B63-ijms-20-05378]\]. Furthermore, an abundance of deiminated complement components identified in both plasma and plasma-EVs may indicate roles for functional diversity of the complement system via post-translational deimination in the naked mole-rat. This may play various roles in naked mole-rat immune responses as recent studies have identified some unusual characteristics, including atypical immune surveillance and a greater reliance on myeloid-biased innate immunity \[[@B64-ijms-20-05378]\]. Also noteworthy is the identification of deiminated adiponectin in naked mole-rat plasma identified here, as adiponectin in humans is the most abundant secreted adipokine with pleiotropic roles in metabolism \[[@B65-ijms-20-05378],[@B66-ijms-20-05378]\], glucose regulation \[[@B67-ijms-20-05378],[@B68-ijms-20-05378],[@B69-ijms-20-05378]\], longevity \[[@B70-ijms-20-05378]\], regeneration and cancer \[[@B71-ijms-20-05378],[@B72-ijms-20-05378],[@B73-ijms-20-05378]\]. Such deimination of adiponectin has not been studied and may add to some of its protein moonlighting function and be of relevance in the context of the unusual metabolism of the naked mole-rat.

As part of EV-mediated cellular communication in physiology and pathologies, the transport of microRNAs (miRs) is well acknowledged. There is increasing interest, reflected in a range of studies, in furthering our understanding of how such EV-mediated transport may play a part in physiological and pathophysiological processes. MiRs are highly conserved small non-coding RNAs that control gene expression and regulate biological processes by targeting messenger RNAs (mRNAs). MiRs can, for example, inhibit post-transcriptional translation of mRNA as well as enhance mRNA degradation \[[@B74-ijms-20-05378]\]. Some expression profiling has been carried out in naked mole-rats, mainly at the transcriptome level \[[@B75-ijms-20-05378],[@B76-ijms-20-05378]\], although no studies have assessed miRs in EVs of naked mole-rat plasma. This study focused on assessing three key miRs known to be involved in cancer, inflammation and hypoxia due to the unusual resistance of naked mole-rats to cancer, ageing and hypoxia. MiR21 is a main immunoregulatory and onco-related miR and is also associated with chronic diseases \[[@B77-ijms-20-05378],[@B78-ijms-20-05378],[@B79-ijms-20-05378]\]. MiR21 is strongly conserved throughout evolution and while many experimentally verified targets of miR21 are tumour suppressors, miR21 is also linked to cardiac disease and oxidative stress \[[@B80-ijms-20-05378]\]. Less is known about the physiological roles of miR21. In the current study, miR21 was found to be by far the highest miR expressed in EVs of naked mole-rat out of the three miRs tested. Roles for miR21 in immune responses of naked mole-rat have not been reported in detail and the expression of miR21 in EVs has not been assessed in naked mole-rat before.

In mammals, miR155 is known to be a major inflammatory related miR, linked to inflammatory and stress responses \[[@B81-ijms-20-05378]\]. Here, miR155 was found to be the least expressed of the three miRs tested in naked mole-rat plasma-EVs, possibly indicating that this miR may be a contributing factor to the "anti-inflammatory" state of mole-rats, which may have some relation to their longevity and cancer resistance. MiR210 is known to be a major miR induced under hypoxia and has an important role in mitochondrial metabolism, DNA damage response, cell proliferation and apoptosis \[[@B74-ijms-20-05378]\]. MiR210 has an important role in regulating mitochondrial metabolism \[[@B82-ijms-20-05378]\] and cell glycolytic activity, as well as being linked to inflammation \[[@B83-ijms-20-05378]\]. MiR210 has been identified as a regulator of the hypoxia pathway and was found to have pro-apoptotic functions under normoxic conditions, but anti-apoptotic effects under hypoxic conditions \[[@B84-ijms-20-05378],[@B85-ijms-20-05378]\]. In the current study, miR210 was found to be more highly expressed in mole-rat plasma than the inflammatory miR155. As naked mole-rats are known to be hypoxia tolerant animals and to exhibit marked changes in their metabolic substrate use and metabolic demand in hypoxia \[[@B41-ijms-20-05378],[@B86-ijms-20-05378]\], miR210 may have functional roles in metabolic control, possibly contributing to the well-known longevity of these animals. As this is the first study to assess the expression of these three onco-, inflammatory- and metabolic-related miRs in naked mole-rat plasma-EVs, it remains to be fully understood what specific functions the EV-mediated transport of these miRs play in the unusual physiology of naked mole-rats.

Here, for the first time, we report the protein deimination profiles of plasma and plasma-derived EVs in naked mole-rats. Post-translational deimination of major key immune and metabolic factors in naked mole-rats was identified and related to key KEGG pathways of inflammation, metabolism and oxygen transport. Our findings highlight novel aspects of protein moonlighting via post-translational deimination, including via EV-mediated transport. Research on EVs is a relatively new field in comparative animal models, and to our knowledge this is the first characterisation of EVs and associated protein and selected miR cargo markers in naked mole-rats. Furthermore, as PADs have been found to play major roles in the regulation of EV release \[[@B19-ijms-20-05378],[@B20-ijms-20-05378],[@B21-ijms-20-05378],[@B22-ijms-20-05378],[@B34-ijms-20-05378]\], their contribution to EV-mediated cell communication in response to physiological and pathophysiological changes in naked mole-rats remains to be further investigated. Findings in long-lived mammals that display cancer resistance, including naked mole-rats, may be of considerable translational value for furthering our understanding of the mechanisms underlying cancer resistance for improved development of human cancer therapies \[[@B59-ijms-20-05378]\].

In continuation of the current study, the assessment of changes in deiminated proteins and EV profiles, including protein and genetic EV-cargo, may be of great interest in studies using this unique animal model to further understanding of the hitherto novel and understudied mechanisms involved in cancer and ageing.

4. Materials and Methods {#sec4-ijms-20-05378}
========================

4.1. Sampling of Naked Mole-Rat Plasma {#sec4dot1-ijms-20-05378}
--------------------------------------

Naked mole-rats were group-housed in interconnected multi-cage systems at 30 °C and 21% O~2~ in 50% humidity with a 12L:12D light cycle. Animals were fed fresh tubers, vegetables, fruit and Pronutro cereal supplement ad libitum. Animals were not fasted prior to experimental trials. All experimental procedures were approved by the University of Ottawa Animal Care Committee in accordance with the Animals for Research Act and by the Canadian Council on Animal Care (protocol \# 2535). Non-breeding (subordinate) naked mole-rats do not undergo sexual development or express sexual hormones and thus we did not take sex into consideration when evaluating our results \[[@B87-ijms-20-05378]\]. Blood was collected from 12 adult (\~ 1--2 years old) subordinate naked mole-rats following live cervical dislocation and rapid decapitation. Blood was collected in Eppendorf tubes pre-coated with a 10% EDTA (ethylenediaminetetraacetic acid) solution. Plasma was isolated by centrifugation at 5000× *g* for 5 min. The isolated plasma was aliquoted and immediately frozen at −80 °C until further use.

4.2. Extracellular Vesicle Isolation and Nanoparticle Tracking Analysis (NTA) {#sec4dot2-ijms-20-05378}
-----------------------------------------------------------------------------

EVs were isolated by step-wise centrifugation according to our established protocols using ultracentrifugation and the recommendations of MISEV2018 (the minimal information for studies of extracellular vesicles 2018; \[[@B88-ijms-20-05378]\]). Mole-rat plasma were diluted 1:4 in ultra-filtered (using a 0.22 μm filter) Dulbecco's PBS (100 μL plasma added to 400 μL DPBS) and then centrifuged at 4000× *g* for 30 min at 4 °C for removal of aggregates and apoptotic bodies. The supernatants were collected and centrifuged further at 100,000× *g* for 1 h at 4 °C. The EV-enriched pellets were washed in 1 mL DPBS and ultra-centrifuged at 100,000× *g* for 1 h at 4 °C. The final EV pellets were resuspended in 100 µL DPBS and frozen at −80 °C until further use. For NTA, based on Brownian motion of particles in suspension, the EV pellets were diluted 1/100 in DPBS and applied to the NanoSight NS300 system (Malvern Panalytical Ltd., Malvern, UK) in conjunction with a syringe pump to ensure continuous flow of the sample. Five 60 sec videos were recorded for each sample, with approximately 40--60 particles per frame, and the replicate histograms generated were averaged.

4.3. Transmission Electron Microscopy (TEM) {#sec4dot3-ijms-20-05378}
-------------------------------------------

EVs were isolated from individual plasma as described above. For TEM, the EV pellets were fixed with 2.5% glutaraldehyde in 100 mM sodium cacodylate buffer (pH 7.0) for 1 h at 4 °C. The EVs were then resuspended in 100 mM sodium cacodylate buffer (pH 7.0), placed on to a grid with a glow discharged carbon support film and stained with 2% aqueous Uranyl Acetate (Sigma-Aldrich, Gillingham, UK). Individual EVs were imaged by TEM using a Morada CCD camera (EMSIS GmbH, Münster, Germany) and processed via iTEM (EMSIS).

4.4. Western Blotting Analysis {#sec4dot4-ijms-20-05378}
------------------------------

Mole-rat plasma and plasma-EVs (an EV pellet derived from 100 µL plasma, reconstituted in 100 µL PBS) were diluted 1:1 in 2 × Laemmli sample buffer, boiled for 5 min at 100 °C and separated by SDS-PAGE on 4--20% TGX gels (BioRad, Watford, UK). Approximately 5 μg protein was loaded per lane. Following SDS-PAGE, proteins were transferred to nitrocellulose membranes using semi-dry Western blotting; even transfer was assessed by PonceauS (Sigma-Aldrich, Gillingham, UK) staining. The membranes were blocked in 5% BSA in TBS-T for 1 h at room temperature (RT) and thereafter incubated with the following primary antibodies diluted in TBS-T: F95 pan-deimination antibody (MABN328, Merck, Watford, UK, 1/1000); PAD2 (ab50257, Abcam, Cambridge, UK, 1/1000); PAD3 (ab50246, Abcam, 1/1000); PAD4 (ab50247, Abcam, 1/1000); and two EV-specific markers: CD63 (ab216130, Abcam, 1/1000); Flot-1 (ab41927, Abcam, 1/2000). After primary antibody incubation overnight at 4 °C on a shaking platform, the membranes were washed for 3 × 10 min in TBS-T at RT and thereafter incubated with the appropriate HRP-conjugated secondary antibodies (anti-rabbit IgG BioRad or anti-mouse IgM BioRad, diluted 1/4000 in TBS-T) for 1 h, at RT. Membranes were washed for 5 × 10 min in TBS-T, followed by 1 × 10 min in TBS proteins bands were visualised using enhanced chemiluminescence (ECL, Amersham, Buckinghamshire, UK) and digital images were obtained using the UVP BioDoc-ITTM System (Thermo Fisher Scientific, Hemel Hempstead, UK).

4.5. Immunoprecipitation and Protein Identification {#sec4dot5-ijms-20-05378}
---------------------------------------------------

Deiminated proteins in plasma and in plasma-derived EVs were immunoprecipitated by enrichment with the F95 pan-deimination antibody (MABN328, Merck, Watford, UK), which has been developed against a deca-citrullinated peptide and specifically detects proteins modified by citrullination \[[@B89-ijms-20-05378]\]. The mono-specific F95 antibody is predicted to react with all deiminated/citrullinated proteins based on 100% sequence homology and has for example been used to identify deiminated proteins in human, mouse, rat, chicken and teleost fish tissue \[[@B11-ijms-20-05378],[@B12-ijms-20-05378],[@B16-ijms-20-05378],[@B18-ijms-20-05378],[@B19-ijms-20-05378],[@B21-ijms-20-05378],[@B22-ijms-20-05378],[@B31-ijms-20-05378],[@B89-ijms-20-05378]\]. The Catch and Release immunoprecipitation kit (Merck, Watford, UK) was used according to the manufacturer's instructions. For F95 enrichment, plasma was pooled from 5 individual animals (5 × 20 μL), while for EVs, total protein was first extracted from the EV pellets derived from 100 μL plasma per animal, using 100 μL RIPA + buffer on ice for 2 h followed by centrifugation at 16,000× *g* for 30 min to collect the supernatant containing the proteins. The immunoprecipitation was carried out on a rotating platform overnight at 4 °C, and the F95 bound proteins were eluted using denaturing elution buffer according to the manufacturer's instructions (Merck). The F95 enriched eluates were then either analysed by Western blotting or by liquid chromatography with tandem mass spectrometry (LC-MS/MS; Cambridge Proteomics, Cambridge, UK). Peak files obtained were submitted to Mascot (Matrix Science). An in-house database (Cambridge proteomics) for naked mole-rat was used for the identification of species-specific protein hits (CCP_Heterocephalus_glaber Heterocephalus_glaber_20190911; 21449 sequences; 10466552 residues).

4.6. MicroRNA Analysis {#sec4dot6-ijms-20-05378}
----------------------

EV isolates from individual naked mole-rat plasma (from 100 μL plasma as before) were assessed for relative expression of 3 key microRNAs (miRs) related to oncogenic, inflammatory and metabolic activity. These selected miRs included two cancer and immune-related miRs, miR21 and miR155, and miR210 for hypoxia and metabolic activity. Total RNA was extracted from mole-rat plasma EVs (prepared as before) using Trizol (Sigma-Aldrich, Gillingham, UK). The purity and concentration of the isolated RNA were measured using the NanoDrop Spectrophotometer at 260 nm and 280 nm absorbance. The cDNA was produced using the qScript microRNA cDNA Synthesis Kit (Quantabio, Beverly, MA, USA) according to the manufacturer's instructions and used to assess the expression of miR21, miR155 and miR210. Reference RNAs used for the normalization of miR expression levels were U6-snRNA and has-let-7a-5p. The PerfeCTa SYBR Green SuperMix (Quantabio, Beverly, MA, USA) was used together with MystiCq microRNA qPCR primers for the miR21 (hsa-miR-21-5p), mir155 (hsa-miR-155-5p) and miR210 (hsa-miR-210-5p). All miR primers were obtained from Sigma-Aldrich (UK). Thermocycling conditions were used as follows: denaturation at 95 °C for 2 min, followed by 40 cycles of 95 °C for 2 s, 60 °C for 15 s, and extension at 72 °C for 15 s. The 2^ΔΔCt^ method \[[@B90-ijms-20-05378]\] was used for calculating relative miR expression levels and for normalisation. Each experiment was performed in 3 individuals, in triplicate.

4.7. Statistical Analysis {#sec4dot7-ijms-20-05378}
-------------------------

The histograms and graphs were prepared using the Nanosigh NS300 software (Malvern Panalytical Ltd., Malvern, UK) and GraphPad Prism version 7 (GraphPad Software, San Diego, CA, USA). Experiments were repeated in triplicate, histograms represent mean of data and standard error of mean (SEM) is indicated by the error bars. Significant differences were considered as *p* ≤ 0.05, following one-way ANOVA or Student's t-test.

5. Conclusions {#sec5-ijms-20-05378}
==============

Here, for the first time, we report the protein deimination profiles of plasma and plasma-derived EVs in naked mole-rats. Post-translational deimination of major key immune and metabolic proteins in naked mole-rats was identified and related to key KEGG pathways of inflammation, metabolism and oxygen transport. Our findings highlight novel aspects of protein moonlighting via post-translational deimination, including via EV-mediated transport of such proteins in cellular communication. Three key microRNAs for oncogenic, inflammatory and metabolic/hypoxia function were also assessed in mole-rat plasma EVs. In continuation of the current study, the assessment of changes in deiminated proteins and EV profiles, including protein and microRNA EV-cargo may be of great interest in studies using this unique animal model to further understanding of hitherto novel and understudied mechanisms involved in cancer, inflammatory diseases and ageing.
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Click here for additional data file.

Supplementary materials can be found at <https://www.mdpi.com/1422-0067/20/21/5378/s1>. Supplementary Table S1. Deiminated proteins identified by F95 enrichment in total plasma of naked mole-rat (*Heterocephalus glaber*). Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC-MS/MS and peak list files were submitted to mascot. Peptide sequences for the protein hits, their m/z values and individual scores are listed. Supplementary Table S2. Deiminated proteins identified by F95 enrichment in plasma-EVs of naked mole-rat (*Heterocephalus glaber*). Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC-MS/MS and peak list files were submitted to mascot. Peptide sequences for the protein hits, their m/z values and individual scores are listed.
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![Peptidylarginine deiminases (PADs) and deiminated proteins in naked mole-rat plasma and plasma-extracellular vesicles (EVs). (**A**) PAD positive bands were identified at the expected size of approximately 70--75 kDa using the human PAD2, PAD3 and PAD4 specific antibodies in naked mole-rat plasma. (**B**) Total deiminated proteins were identified in naked mole-rat plasma (*n* = 4) using the F95 pan-deimination specific antibody. (**C**) Total deiminated proteins were identified in naked mole-rat plasma-EVs using the F95 pan-deimination specific antibody (EV pools from plasma of 4 individuals are shown, respectively). (**D**) The F95-enriched IP fraction from mole-rat plasma (from a pool of 5 individual mole-rat plasma; F95_IP) is shown. The molecular weight marker is indicated next to each blot.](ijms-20-05378-g001){#ijms-20-05378-f001}

![Deiminated proteins identified in naked mole-rat plasma and plasma-EVs. Species specific hits identified for deiminated proteins in naked mole-rat plasma and EVs showed 112 total proteins identified in plasma and 80 in EVs, respectively. Of these, 48 protein hits were overlapping, while 64 proteins were specific for whole plasma and 32 for plasma-EVs only, respectively.](ijms-20-05378-g002){#ijms-20-05378-f002}

###### 

Protein-protein interaction networks of deiminated proteins identified in naked mole-rat plasma. Reconstruction of protein-protein interactions based on known and predicted interactions using STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) analysis. (**A**) Coloured nodes represent query proteins and first shell of interactors. (**B**) KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways relating to the identified proteins and reported in STRING are highlighted as follows: red = complement and coagulation cascade; dark green = *Staphylococcus aureus* infection; purple = pertussis; yellow = platelet activation; light blue = systemic lupus erythematosus (SLE); orange = prion diseases; dark blue = cholesterol metabolism; light green = vitamin digestion and absorption; dark red = ferroptosis; pink = drug metabolism. Coloured nodes represent query proteins and first shell of interactors; white nodes are second shell of interactors. Coloured lines indicate whether protein interactions are identified via known interactions (curated databases, experimentally determined), predicted interactions (gene neighbourhood, gene fusion, gene co-occurrence) or via text mining, co-expression or protein homology (see the colour key for connective lines included in the figure).

![](ijms-20-05378-g003a)

![](ijms-20-05378-g003b)

![Protein-protein interaction networks of deiminated proteins identified in plasma-EVs of naked mole-rat. Reconstruction of protein-protein interactions based on known and predicted interactions using STRING analysis. (**A**) Coloured nodes represent query proteins and first shell of interactors. (**B**) KEGG pathways relating to the identified proteins and reported in STRING are highlighted as follows: red = complement and coagulation cascade; dark green = *Staphylococcus aureus* infection; purple = HIF-signalling pathway; yellow = platelet activation; light blue = systemic lupus erythematosus (SLE); orange = oestrogen signalling pathway; dark blue = cholesterol metabolism; light green = vitamin digestion and absorption; pink = glycolysis/gluconeogenesis. Coloured nodes represent query proteins and first shell of interactors, white nodes are second shell of interactors. Coloured lines indicate whether protein interactions are identified via known interactions (curated databases, experimentally determined), predicted interactions (gene neighbourhood, gene fusion, gene co-occurrence) or via text mining, co-expression or protein homology (see the colour key for connective lines included in the figure).](ijms-20-05378-g004){#ijms-20-05378-f004}

![Extracellular vesicle profiling in naked mole-rat plasma. (**A**) Nanoparticle tracking analysis (NTA) shows a size distribution of EVs from naked mole-rat in the range of mainly 50 to 300 nm, with representative NTA profiles of EVs from 3 different animals (NTA-1, NTA-2, NTA-3). (**B**) Western blotting analysis confirms that naked mole-rat EVs are positive for the phylogenetically conserved EV-specific markers CD63 and Flot-1. (**C**) Transmission electron microscopy (TEM) analysis of naked mole-rat plasma-derived EVs shows typical EV morphology; a composite figure is shown and the scale bar (100 nm) applies for all images in the panel. (**D**) EV yield in plasma of 12 individual naked mole-rats is shown. (**E**) EV modal size in plasma of 12 individual naked mole-rats is presented.](ijms-20-05378-g005){#ijms-20-05378-f005}

![MicroRNA (miR) analysis of three key miRs related to cancer, inflammation, metabolism and hypoxia, in naked mole-rat plasma-derived EVs. (**A**). The onco-related miR21 showed the highest relative expression of the three miRs tested, being 394-fold higher than miR155 and 153-fold higher than miR210, respectively (*p* \< 0.0001; *n* = 3). (**B**). The relative expression of the hypoxia and metabolic related miR210 was 2.6--fold higher than the inflammatory miR155 (*p* = 0.0002; *n* = 3); (miR21, miR155 and miR210 expression is represented as red circles, orange squares and blue triangles, respectively).](ijms-20-05378-g006){#ijms-20-05378-f006}
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###### 

Deiminated proteins identified by F95 enrichment in total plasma of naked mole-rat (*Heterocephalus glaber*). Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC-MS/MS and peak list files were submitted to mascot. Species-specific peptide sequence hits scoring with *H. glaber* are included and total score is shown. Protein hits identified in whole plasma only (but not in plasma EVs) are highlighted in pink. For full LC-MS/MS data analysis see [Supplementary Table S1](#app1-ijms-20-05378){ref-type="app"}.

  Protein Name                                                           Symbol          Total Score (*p* \< 0.05) ^\#^
  ---------------------------------------------------------------------- --------------- --------------------------------
  Apolipoprotein B-100                                                   G5AZB7_HETGA    6077
  Alpha-2-macroglobulin                                                  G5BPM1_HETGA    4974
  Complement C3                                                          G5C0N5_HETGA    4300
  Serotransferrin                                                        G5BQA9_HETGA    4058
  Serum albumin                                                          G5B5P2_HETGA    3394
  Fibronectin                                                            G5BHR4_HETGA    3333
  Fibrinogen beta chain                                                  G5BML3_HETGA    2638
  Kininogen-1                                                            G5BT86_HETGA    2276
  Fibrinogen alpha chain                                                 G5BML2_HETGA    2094
  Ceruloplasmin                                                          G5BSL1_HETGA    2022
  Histidine-rich glycoprotein                                            G5BT87_HETGA    1851
  Complement C4-A                                                        G5C3H6_HETGA    1759
  Complement factor H                                                    G5BM71_HETGA    1646
  Plasminogen                                                            G5BC53_HETGA    1548
  Inter-alpha-trypsin inhibitor heavy chain H4                           G5BUN4_HETGA    1455
  Fibrinogen gamma chain                                                 G5BML1_HETGA    1338
  Complement factor B                                                    G5C3H1_HETGA    1313
  Plasma kallikrein                                                      G5BNV2_HETGA    1167
  Antithrombin-III                                                       G5ARS6_HETGA    1093
  Coagulation factor V                                                   G5CB46_HETGA    1092
  Complement C5                                                          G5AXS5_HETGA    1002
  Hemoglobin subunit beta                                                G5BS33_HETGA    941
  Transcobalamin-2 isoform 1                                             G5AVP0_HETGA    913
  Hemopexin                                                              G5BBR0_HETGA    899
  Coagulation factor XIII B chain                                        G5BM72_HETGA    821
  Protein AMBP                                                           G5B1Y4_HETGA    817
  N-acetylmuramoyl-L-alanine amidase                                     G5BYP3_HETGA    812
  Coagulation factor XII                                                 G5BQ09_HETGA    802
  Apolipoprotein A-I                                                     APOA1_HETGA     798
  Hemoglobin subunit alpha                                               G5BXY1_HETGA    784
  Coagulation factor XIII A chain                                        G5BAS8_HETGA    779
  Hemoglobin subunit beta                                                G5BYJ8_HETGA    759
  Alpha-1-antiproteinase S                                               G5B496_HETGA    724
  Inter-alpha-trypsin inhibitor heavy chain H3                           G5BUN3_HETGA    682
  Vitronectin                                                            G5BVN8_HETGA    652
  Complement factor I                                                    G5AQM1_HETGA    647
  Hemoglobin subunit epsilon-1                                           G5BS35_HETGA    642
  Inter-alpha-trypsin inhibitor heavy chain H2                           G5AXV8_HETGA    584
  Apolipoprotein E                                                       G5CBM7_HETGA    581
  Inhibitor of carbonic anhydrase                                        G5BQB0_HETGA    537
  Inter-alpha-trypsin inhibitor heavy chain H1                           G5BUN2_HETGA    482
  Four and a half LIM domains protein 1                                  G5CA61_HETGA    469
  Haptoglobin                                                            G5B5U6_HETGA    464
  C4b-binding protein                                                    G5BP10_HETGA    438
  L-lactate dehydrogenase                                                G5AKA3_HETGA    437
  Insulin-like growth factor-binding protein complex acid labile chain   G5BY64_HETGA    403
  Catalase                                                               G5AXV0_HETGA    382
  Fetuin-B                                                               G5BT88_HETGA    347
  Alpha-2-HS-glycoprotein                                                G5BT89_HETGA    337
  Selenoprotein P                                                        G5APA7_HETGA    328
  Vitamin D-binding protein                                              G5BE53_HETGA    317
  Adiponectin                                                            G5BT83_HETGA    283
  von Willebrand factor                                                  G5CAN6_HETGA    274
  Beta-2-glycoprotein 1                                                  G5BGY7_HETGA    268
  Basement membrane-specific heparan sulfate proteoglycan core protein   G5BI06_HETGA    267
  Gelsolin                                                               G5AXS0_HETGA    259
  Aspartyl aminopeptidase                                                G5AKJ4_HETGA    256
  Complement C1q subcomponent subunit A                                  G5BHZ8_HETGA    246
  Ficolin-3                                                              G5AUT5_HETGA    241
  Mannan-binding lectin serine protease 1                                G5BTD5_HETGA    228
  Alpha-1-antichymotrypsin                                               G5B491_HETGA    228
  Carboxypeptidase N catalytic chain                                     G5AYP3_HETGA    210
  Complement C1q subcomponent subunit C                                  G5BHZ7_HETGA    191
  Mannan-binding lectin serine protease 2                                G5C521_HETGA    188
  Prothrombin                                                            G5ATC4_HETGA    177
  Complement C1q tumour necrosis factor-related protein 3                G5BQ97_HETGA0   177
  Nucleoside diphosphate kinase                                          G5C4L3_HETGA    168
  L-lactate dehydrogenase                                                G5BEG2_HETGA    167
  Alpha-2-antiplasmin                                                    G5BCV1_HETGA    164
  Keratin, type II cytoskeletal 6B                                       G5ALS1_HETGA    152
  Carbonic anhydrase 2                                                   G5ATW7_HETGA    143
  Proprotein convertase subtilisin/kexin type 9                          G5APQ4_HETGA    137
  Angiotensinogen                                                        G5BQI5_HETGA    121
  6-phosphogluconate dehydrogenase, decarboxylating                      G5C530_HETGA    91
  Nesprin-1                                                              G5C0E1_HETGA    87
  Complement C1q subcomponent subunit B                                  G5BHZ6_HETGA    87
  Angiopoietin-related protein 6                                         G5B341_HETGA    85
  Hepatocyte growth factor activator                                     G5BZF5_HETGA    84
  Calpain-1 catalytic subunit                                            G5B6L3_HETGA    84
  Sulfhydryl oxidase                                                     G5AYL7_HETGA    80
  Keratin, type II cytoskeletal 5                                        G5ALS3_HETGA    76
  Profilin                                                               G5BH50_HETGA    75
  40S ribosomal protein S27a                                             G5B8W4_HETGA    68
  Xanthine dehydrogenase/oxidase                                         G5B3Z0_HETGA    68
  Plasma protease C1 inhibitor                                           G5BLJ5_HETGA    67
  Collectin-11                                                           G5C7L1_HETGA    66
  Extracellular matrix protein 1                                         G5BH40_HETGA    64
  Actin, gamma-enteric smooth muscle                                     G5AXH0_HETGA    61
  Collectin-10                                                           G5C9R8_HETGA    61
  Keratin, type I cytoskeletal 17                                        G5B0M4_HETGA    58
  Contactin-1                                                            G5BGJ6_HETGA    55
  Dynein heavy chain 1, axonemal                                         G5BUL8_HETGA    50
  Leucine-rich repeat-containing protein 15                              G5ALE6_HETGA    43
  Transcriptional regulator ATRX                                         G5C0I5_HETGA    42
  Transmembrane protein 127                                              G5BMW1_HETGA    41
  TRAF3-interacting protein 1                                            G5BHH8_HETGA    41
  Mannose-binding protein A                                              G5C4H7_HETGA    40
  Hyaluronan-binding protein 2                                           G5BKD5_HETGA    39
  Fer3-like protein                                                      G5BZJ1_HETGA    38
  Complement component C7                                                G5C4R4_HETGA    38
  PITH domain-containing protein                                         G5BHY3_HETGA    38
  1,4-alpha-glucan-branching enzyme                                      G5BA56_HETGA    37
  tRNA pseudouridine synthase                                            G5BB54_HETGA    37
  SRRM2-like protein                                                     G5BG61_HETGA    34
  Putative carboxypeptidase PM20D1                                       G5BX50_HETGA    34
  Olfactory receptor                                                     G5C741_HETGA    33
  Protein CASC5                                                          G5BLZ4_HETGA    33
  Conserved oligomeric Golgi complex subunit 1                           G5B5M3_HETGA    32
  Small G protein signalling modulator 1                                 G5BGN5_HETGA    32
  Eukaryotic translation initiation factor 3 subunit E                   G5BD61_HETGA    31
  HEAT repeat-containing protein 2                                       G5AZ15_HETGA    31
  Proline-rich protein 11                                                G5AXY5_HETGA    31
  Peroxiredoxin-1                                                        G5ARW1_HETGA    30
  Pre-mRNA-processing factor 17                                          G5B0Y2_HETGA    30
  Ribonucleoside-diphosphate reductase                                   G5B9C2_HETGA    30

^\#^ Ions score is −10 \* Log(*p*), where *p* is the probability that the observed match is a random event. Individual ions scores \> 30 indicate identity or extensive homology (*p* \< 0.05). Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 30. Protein hits identified in whole plasma only (but not in plasma EVs) are highlighted in pink.
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###### 

Deiminated proteins identified by F95 enrichment in plasma-derived EVs of naked mole-rat (*Heterocephalus glaber*). Deiminated proteins were isolated by immunoprecipitation using the pan-deimination F95 antibody. The F95 enriched eluate was analysed by LC-MS/MS and peak list files were submitted to mascot. Species-specific peptide sequence hits scoring with *H. glaber* are included and total score is shown. Protein hits identified in plasma-EVs only are highlighted in blue. For full LC-MS/MS data analysis see [Supplementary Table S2](#app1-ijms-20-05378){ref-type="app"}.

  Protein Name                                                             Symbol         Total Score (*p* \< 0.05) ^\#^
  ------------------------------------------------------------------------ -------------- --------------------------------
  Alpha-2-macroglobulin                                                    G5BPM1_HETGA   2978
  Serum albumin                                                            G5B5P2_HETGA   2570
  Serotransferrin                                                          G5BQA9_HETGA   1976
  Keratin, type II cytoskeletal 6B                                         G5ALS1_HETGA   1459
  Complement C3                                                            G5C0N5_HETGA   1440
  Keratin, type II cytoskeletal 5                                          G5ALS3_HETGA   1211
  Kininogen-1                                                              G5BT86_HETGA   1196
  Histidine-rich glycoprotein                                              G5BT87_HETGA   1186
  Keratin, type I cytoskeletal 10                                          G5AX66_HETGA   1130
  Keratin, type I cytoskeletal 14                                          G5B0M6_HETGA   1038
  Keratin, type II cytoskeletal 1                                          G5ALS8_HETGA   1011
  Fibrinogen beta chain                                                    G5BML3_HETGA   974
  Fibrinogen alpha chain                                                   G5BML2_HETGA   956
  Apolipoprotein B-100                                                     G5AZB7_HETGA   834
  Keratin, type I cytoskeletal 13                                          G5B0N0_HETGA   701
  Keratin, type I cytoskeletal 17                                          G5B0M4_HETGA   673
  Desmoplakin                                                              G5BAT4_HETGA   670
  Hemoglobin subunit alpha                                                 G5BXY1_HETGA   591
  Hemoglobin subunit beta                                                  G5BS33_HETGA   581
  Complement C4-A                                                          G5C3H6_HETGA   571
  Hemoglobin subunit beta                                                  G5BYJ8_HETGA   568
  Apolipoprotein A-I                                                       APOA1_HETGA    499
  Keratin, type II cytoskeletal 79                                         G5BJ37_HETGA   468
  Actin, cytoplasmic 1                                                     G5BI78_HETGA   444
  Keratin, type II cytoskeletal 4                                          G5BJ36_HETGA   443
  Fibrinogen gamma chain                                                   G5BML1_HETGA   382
  Ceruloplasmin                                                            G5BSL1_HETGA   350
  Apolipoprotein E                                                         G5CBM7_HETGA   338
  Inter-alpha-trypsin inhibitor heavy chain H4                             G5BUN4_HETGA   332
  Protein AMBP                                                             G5B1Y4_HETGA   280
  Inhibitor of carbonic anhydrase                                          G5BQB0_HETGA   244
  Hemopexin                                                                G5BBR0_HETGA   239
  Histone H4                                                               G5BKL3_HETGA   238
  Plasminogen                                                              G5BC53_HETGA   232
  Alpha-1-antiproteinase S                                                 G5B496_HETGA   217
  Hemoglobin subunit epsilon-1                                             G5BS35_HETGA   213
  Junction plakoglobin                                                     G5B0M0_HETGA   202
  N-acetylmuramoyl-L-alanine amidase                                       G5BYP3_HETGA   190
  Inter-alpha-trypsin inhibitor heavy chain H3                             G5BUN3_HETGA   190
  Keratin, type II cytoskeletal 7                                          G5BL96_HETGA   182
  Fibronectin                                                              G5BHR4_HETGA   164
  Glyceraldehyde-3-phosphate dehydrogenase                                 G5CAP7_HETGA   154
  Coagulation factor XII                                                   G5BQ09_HETGA   152
  Antithrombin-III                                                         G5ARS6_HETGA   150
  Catenin beta-1                                                           G5ALX2_HETGA   126
  Plakophilin-1                                                            G5B3A4_HETGA   120
  Annexin                                                                  G5AWC0_HETGA   119
  Keratin, type II cytoskeletal 3                                          G5ALT2_HETGA   118
  40S ribosomal protein S27a                                               G5B8W4_HETGA   116
  Inter-alpha-trypsin inhibitor heavy chain H2                             G5AXV8_HETGA   106
  Alpha-2-antiplasmin                                                      G5BCV1_HETGA   86
  Complement factor B                                                      G5C3H1_HETGA   81
  Elongation factor 1-alpha                                                G5ALK7_HETGA   78
  Angiotensinogen                                                          G5BQI5_HETGA   77
  Histone H2B                                                              G5BH20_HETGA   77
  Plasma kallikrein                                                        G5BNV2_HETGA   72
  Beta-enolase                                                             G5BW96_HETGA   70
  Vitamin D-binding protein                                                G5BE53_HETGA   57
  Alpha-1-antichymotrypsin                                                 G5B491_HETGA   55
  Keratin, type II cytoskeletal 80                                         G5BL95_HETGA   53
  Heat shock cognate 71 kDa protein                                        G5B170_HETGA   51
  Leucine-rich repeat-containing protein KIAA1731                          G5C3Y1_HETGA   50
  Cathepsin D                                                              G5C2G1_HETGA   49
  Basement membrane-specific heparan sulfate proteoglycan core protein     G5BI06_HETGA   47
  Skin-specific protein 32                                                 G5BUY9_HETGA   46
  Desmocollin-1                                                            G5C312_HETGA   46
  Protein-arginine deiminase type-6                                        G5BZN1_HETGA   46
  Cryptochrome-1                                                           G5C454_HETGA   45
  Complement C1q subcomponent subunit C                                    G5BHZ7_HETGA   45
  p2Y purinoceptor 12                                                      G5C102_HETGA   44
  Alpha-1B-glycoprotein                                                    G5B7K8_HETGA   44
  Exportin-1                                                               G5C1Y9_HETGA   44
  Putative hexokinase HKDC1                                                G5B183_HETGA   43
  Transcriptional regulator ATRX                                           G5C0I5_HETGA   42
  Coiled-coil domain-containing protein 57                                 G5BJ98_HETGA   42
  Microtubule plus-end tracking protein TIP150                             G5ATU1_HETGA   40
  Tubulin alpha-1C chain                                                   G5AQ00_HETGA   38
  Fer3-like protein                                                        G5BZJ1_HETGA   38
  Amino acid transporter                                                   G5BYQ9_HETGA   36
  Ventricular zone-expressed PH domain-containing protein-like protein 1   G5B253_HETGA   35
  SRRM2-like protein                                                       G5BG61_HETGA   35
  N6-adenosine-methyltransferase 70 kDa subunit                            G5BFU9_HETGA   33
  Proline-rich protein 11                                                  G5AXY5_HETGA   33
  Carbonic anhydrase 2                                                     G5ATW7_HETGA   32
  26S proteasome non-ATPase regulatory subunit 3                           G5BRY1_HETGA   31
  Serine/threonine-protein kinase LATS1                                    G5BMD1_HETGA   31
  Transmembrane gamma-carboxyglutamic acid protein 1                       G5C418_HETGA   31
  Collagen alpha-2(I) chain                                                G5ANK8_HETGA   31
  Bcl-2-associated transcription factor 1                                  G5C1A7_HETGA   30

^\#^ Ions score is −10 \* Log(*p*), where *p* is the probability that the observed match is a random event. Individual ions scores \> 30 indicated identity or extensive homology (*p* \< 0.05). Protein scores were derived from ions scores as a non-probabilistic basis for ranking protein hits. Cut-off was set at Ions score 30. Protein hits identified in whole plasma only (but not in plasma EVs) are highlighted in blue.
